| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cost of Revenue | $216K | — |
| R&D Expense | $1.4M | -39.2% |
| SG&A Expense | $4.4M | -59.1% |
| Operating Income | -$6.3M | +53.1% |
| Interest Expense | $467 | -99.0% |
| Pre-tax Income | -$6.5M | +71.0% |
| Income Tax | -$296K | +87.4% |
| Net Income | -$6.2M | +69.1% |
| EPS (Basic) | -$15.49 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $5.1M | +41.3% |
| Total Assets | $12.8M | +142.7% |
| Current Liabilities | $3.5M | -30.8% |
| Total Liabilities | $3.5M | -34.8% |
| Stockholders' Equity | $9.3M | +7343.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.5M | +86.4% |
| Financing Cash Flow | $4.0M | -31.7% |
| +70.5% |
| EPS (Diluted) | -$15.49 | +70.5% |